CIK 0001677077 · <br>Emerging growth company
Alzamend Neuro, Inc.
Sign in to watch- Ticker
- ALZN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811822909
- Phone
- 844-722-6333
- Business address
- 480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
- 4 Open-market sale Director sold 2,000 shares at $1.56 ($3,116)
- 4/A Open-market buy Director bought 110,388 shares at an average $1.01 ($110,965)
- 4/A Open-market buy Director bought 110,388 shares at an average $1.01 ($110,965)
- 4/A Derivatives Options or other derivatives
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Director bought 108,388 shares at $1.00 ($108,897)
- 4 Open-market sale Director sold 1,851 shares at $2.07 ($3,825)
- 4 Open-market sale Director sold 3,333 shares at $2.12 ($7,059)
- 4 Open-market sale Director sold 30 shares at $2.29 ($69)
- 4 Open-market sale Director sold 121,791 shares at an average $2.42 ($294,548)
Page 1 of 9 · 170 filings